ibrutinib,zanubrutinib
beigene,janssen,abbvie
['zanubrutinib', 'cll', ' ibru', 'alpine']
final results of the alpine trial #ash22 zanubrutinib demonstrates superior pfs and orr (no os difference) over ibrutinib in pts with r/r cll/sll pfs benefit seen across all major subgroups, including the del(17p)/tp53mut with less aes 
Medical degree at @USAL | Internal Medicine student at @HematoCAUSA | Hematology and Hemotherapy at Hospital Ramón y Cajal @HematoRYC | PhD student at @UAHes